loader
Please Wait
Applying Filters...
menu
    • menu

    FDA Approvals: Sanofi-Aventis’s Suliqua (insulin glargine/lixisenatide) Receives Approval In Europe - Sanofi

    MenuSanofi

    Uploaded: 2021
    News
    Sanofi's Teizeild Recommended For EU Approval For Stage 2 T1D

    15 Nov 2025

    // PRESS RELEASE

    Sanofi Is 'Chasing The Miracles Of Science' In New Campaign

    10 Nov 2025

    // FIERCE PHARMA

    Dupixent Study Meets Endpoints; sBLA Under FDA Priority Review

    07 Nov 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Sanofi 250

    Contact Supplier

    Website

    Pharmtech & Ingredients

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/m_Qi26UsERU
    Xls

    CATEGORY PAGE
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC107029